
Coral Genomics
New clinical tests for managing autoimmune treatments.
Hakkında
İngilizce şirket açıklaması
Coral integrates molecular, functional, and clinical factors to create new clinical laboratory tests that predict optimal treatments for autoimmune diseases.
We have also identified a unique subpopulation of patients who do not respond to current therapies and are working towards addressing this unmet medical need.
Konular
- Konum
- San Francisco, CA, ABD
- Ekip büyüklüğü
- 5 çalışan
- YC dönemi
- Summer 2018
- Durum
- Satın alındı
- Aşama
- Erken aşama





